Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Archer Daniels Midland
ADM
$38.7B
| $3.4M | ﹤0.01% |
70,603
-7,906
| -10% | -$399K |
|
|
HSTO
577
DELISTED
Histogen Inc. Common Stock
HSTO
| $3.37M | ﹤0.01% |
+3,275
| New | +$3.84M |
|
578
Norfolk Southern
NSC
$75.4B
| $3.31M | ﹤0.01% |
37,844
+21,455
| +131% | +$2.09M |
|
579
Intel
INTC
$413B
| $3.28M | ﹤0.01% |
107,954
-3,878
| -3% | -$125K |
|
580
Berkshire Hathaway Class B
BRK.B
$1.1T
| $3.23M | ﹤0.01% |
23,701
-141
| -0.6% | -$20.1K |
|
581
RLI Corp
RLI
$6.02B
| $3.18M | ﹤0.01% |
123,738
+11,694
| +10% | +$295K |
|
|
PLG
582
Platinum Group Metals
PLG
$160M
| $3.12M | ﹤0.01% |
77,990
-184
| -0.2% | -$8.53K |
|
|
MWE
583
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $3.09M | ﹤0.01% |
54,877
+13,082
| +31% | +$844K |
|
584
Huron Consulting
HURN
$2.76B
| $3.08M | ﹤0.01% |
43,966
-8,212
| -16% | -$538K |
|
585
Reinsurance Group of America
RGA
$15.5B
| $3.07M | ﹤0.01% |
32,362
+13,591
| +72% | +$1.28M |
|
|
AEUA
586
DELISTED
Anadarko Petroleum Corporation
AEUA
| $3.03M | ﹤0.01% |
+60,000
| New | +$3.04M |
|
587
Valero Energy
VLO
$89.5B
| $3M | ﹤0.01% |
47,886
-11,043
| -19% | -$652K |
|
588
Gartner
IT
$11.1B
| $2.98M | ﹤0.01% |
34,740
-165
| -0.5% | -$14.1K |
|
589
Renasant Corp
RNST
$4.04B
| $2.98M | ﹤0.01% |
91,356
+21,171
| +30% | +$646K |
|
590
Glacier Bancorp
GBCI
$6.36B
| $2.89M | ﹤0.01% |
98,230
-2,291
| -2% | -$62.9K |
|
|
UTX.PRA
591
DELISTED
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
| $2.77M | ﹤0.01% |
48,297
| – | – |
|
|
WNRL
592
DELISTED
Western Refining Logistics, LP
WNRL
| $2.76M | ﹤0.01% |
93,837
| – | – |
|
|
TVRD
593
Tvardi Therapeutics
TVRD
$20.1M
| $2.75M | ﹤0.01% |
6,279
+63
| +1% | +$24.3K |
|
|
XNPT
594
DELISTED
XENOPORT, INC.
XNPT
| $2.72M | ﹤0.01% |
443,432
+4,458
| +1% | +$29.2K |
|
|
TEN
595
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $2.71M | ﹤0.01% |
47,254
-6,668
| -12% | -$393K |
|
596
Encompass Health
EHC
$11.3B
| $2.67M | ﹤0.01% |
72,946
-9,473
| -11% | -$338K |
|
597
State Street SPDR S&P Metals & Mining ETF
XME
$3.75B
| $2.64M | ﹤0.01% |
108,643
+9,670
| +10% | +$264K |
|
598
Woodward
WWD
$23B
| $2.64M | ﹤0.01% |
48,053
-2,024
| -4% | -$104K |
|
|
HF
599
DELISTED
HFF Inc.
HF
| $2.63M | ﹤0.01% |
62,918
-2,557
| -4% | -$103K |
|
600
Brunswick
BC
$5.23B
| $2.57M | ﹤0.01% |
50,543
-7,627
| -13% | -$399K |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.